LEN vs VCEL · rev $34.19B vs P/E 835, rev $237.2M
LEN (LEN) versus Vericel Corp Ord (VCEL) — a side-by-side from cached financials, not a winner call.
LEN (LEN) common stock.
Vericel Corp Ord (VCEL) is a biotechnology company listed on US.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
Latest reported VCEL revenue for 2024-12-31 was $237.2M. Net income was $10.4M. Revenue was up 20.1% from 2023-12-31 to 2024-12-31. VCEL currently screens at market cap $2.10B and trailing P/E 834.8.
LEN currently screens at market cap $0. VCEL currently screens at market cap $2.10B and trailing P/E 834.8.
Not investment advice. Open the LEN and VCEL stock pages for the full models.
Not investment advice.